DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Materials
Author Program NEWCreate Narrative
AVNT logo

Avient Corporation Stock Price

NYSE:AVNT Community·US$3.8b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

AVNT Share Price Performance

US$41.72
4.13 (10.99%)
​
US$49.71
Fair Value
US$41.72
4.13 (10.99%)
16.1% undervalued intrinsic discount
US$49.71
Fair Value
Price US$41.72
AnalystConsensusTarget US$49.71
AnalystLowTarget US$46.00
AnalystHighTarget US$56.00
Sat, 8 Aug 26
Fair ValueUS$49.71
Share Pricen/a

AVNT Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$49.71 16.1% undervalued intrinsic discount

High-Performance Healthcare Materials And Sustainable Polymers Will Create Value

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$46 9.3% undervalued intrinsic discount

Healthcare And Defense Materials Will Steadily Support A Fairly Valued Long Term Outlook

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$56 25.5% undervalued intrinsic discount

Defense And Healthcare Materials Will Drive A Stronger Long Term Outlook

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AVNT logo
Avient
9.3% undervalued intrinsic discount
Updated

Healthcare And Defense Materials Will Steadily Support A Fairly Valued Long Term Outlook

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 5 Sep
Read Narrative
AVNT logo
Avient
16.1% undervalued intrinsic discount

High-Performance Healthcare Materials And Sustainable Polymers Will Create Value

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 8 Aug
Read Narrative
AVNT logo
Avient
25.5% undervalued intrinsic discount

Defense And Healthcare Materials Will Drive A Stronger Long Term Outlook

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 22 Aug
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystLowTarget
AVNT logo

AVNT: Pricing And Mix Execution May Support A Measured Re Rating

Fair Value: US$46 9.3% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
AVNT logo

AVNT: Margin Expansion And Pricing Execution Will Support Peer Discount Re Rating

Fair Value: US$56 25.5% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
AVNT logo

AVNT: Portfolio Progress And Margin Expansion Will Support Measured Future Re Rating

Fair Value: US$49.71 16.1% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Undervalued established dividend payer.

2 Risks
5 Rewards
View Full Analysis

Avient Corporation Key Details

US$3.3b

Revenue

US$2.2b

Cost of Revenue

US$1.1b

Gross Profit

US$929.2m

Other Expenses

US$170.0m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
1.85
32.99%
5.10%
76.6%
View Full Analysis

About AVNT

Founded
1885
Employees
9000
CEO
Ashish Khandpur
WebsiteView website
www.avient.com

Avient Corporation operates as a formulator of material solutions in the United States, Canada, Mexico, Europe, South America, and Asia. The company operates in two segments, Color, Additives and Inks; and Specialty Engineered Materials. The Color, Additives and Inks segment offers custom color and additive concentrates in solid and liquid form for thermoplastics, dispersions for thermosets, and specialty inks; custom-formulated liquid system, such as polyester, vinyl, natural rubber and latex, polyurethane, and silicone; and proprietary inks. The company products are used in medical and pharmaceutical devices, food packaging, personal care and cosmetics, transportation, building products, wire and cable, recreational and athletic apparel, construction and filtration, outdoor furniture, healthcare, textiles and appliances, and industrial markets. The Specialty Engineered Materials segment provides specialty polymer formulations, services, and solutions for designers, assemblers, and processors of thermoplastic materials. It sells its products through direct sales personnel, distributors, and commissioned sales agents. The company was formerly known as PolyOne Corporation and changed its name to Avient Corporation in June 2020. Avient Corporation was founded in 1885 and is headquartered in Avon Lake, Ohio.

Recent AVNT News & Updates

User avatar
Narrative Update • Sep 05

AVNT: Pricing And Mix Execution May Support A Measured Re Rating

The analyst fair value estimate for Avient has increased from $42.00 to $46.00, reflecting recent Street price target increases into the $50 to $54 range as analysts cite revenue growth, margin improvement, and stronger execution on pricing and share gains. Analyst Commentary on Avient Recent Street research on Avient has centered on higher price targets and continued Buy ratings, with analysts pointing to revenue growth, margin expansion, and what they see as better execution on pricing and mix.
Seeking Alpha • Aug 24

Avient: Executing According To Plan, Organic Growth Remains Modest

Summary Avient continues to demonstrate strong execution, with margin expansion and differentiated product offerings driving earnings growth despite mixed industry conditions. AVNT's valuation remains reasonable at 14x earnings and 11x EBITDA, supported by improving leverage, now just below 2.5x, and a positive outlook for further margin gains. Organic growth reached 4.3% in Q2, though mostly price-driven, with volume growth expected to improve as data center demand and non-PFAS solutions gain traction. Free cash flow conversion stands at 75% of earnings, reflecting elevated capex; I remain modestly long but may trim if further re-rating occurs. Read the full article on Seeking Alpha

Recent updates

No updates

Avient Corporation Competitors

RGLD logo

Royal Gold

Symbol: NasdaqGS:RGLD
Market cap: US$22.2b
SW logo

Smurfit Westrock

Symbol: NYSE:SW
Market cap: US$22.1b
CDE logo

Coeur Mining

Symbol: NYSE:CDE
Market cap: US$21.6b
SQM logo

Sociedad Química y Minera de Chile

Symbol: NYSE:SQM
Market cap: US$21.6b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide